Application 074292
- Type
- ANDA
- Sponsor
- HOSPIRA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DOBUTAMINE HYDROCHLORIDE | DOBUTAMINE HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 12.5MG BASE/ML | No | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0409-2025 | DOBUTAMINE | DOBUTAMINE | Hospira, Inc. | ANDA | Current |
| 0409-2025 | DOBUTAMINE | DOBUTAMINE | Hospira, Inc. | ANDA | Current |
| 0409-2025 | DOBUTAMINE | DOBUTAMINE | Hospira, Inc. | ANDA | Current |
| 52584-048 | Dobutamine | Dobutamine Hydrochloride Injection | General Injectables and Vaccines, Inc. | ANDA | Current |